The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Wormaway 230/20 mg Flavoured Film-Coated Tablets for Cats

Chanelle Pharmaceuticals Manufacturing LimitedVPA10987/108/001

Main Information

Trade NameWormaway 230/20 mg Flavoured Film-Coated Tablets for Cats
Active SubstancesPyrantel embonate
Dosage FormFilm-coated tablet
Licence HolderChanelle Pharmaceuticals Manufacturing Limited
Licence NumberVPA10987/108/001

Group Information

ATC CodeQP52AA51 praziquantel, combinations
Therapeutic ClassEndoparasiticide


License statusAuthorised
Licence Issued04/07/2013
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back